Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PTO Seeks Early Public Input On Patent Reform Implementation

This article was originally published in The Pink Sheet Daily

Executive Summary

The Patent and Trademark Office has set up a webpage seeking preliminary comments from stakeholders on how to implement key provisions of the legislation nearing enactment.

You may also be interested in...



Patent Reform: Senate May Amend Two Provisions In House Bill

The Senate will vote on whether to limit debate on the House-passed patent reform bill when it reconvenes on Sept. 6. Senate Majority Leader Harry Reid, D-Nev., made a motion for the cloture vote before the August recess in hopes of getting a final bill through Congress quickly.

Patent Reform: Senate May Amend Two Provisions In House Bill

The Senate will vote on whether to limit debate on the House-passed patent reform bill when it reconvenes on Sept. 6. Senate Majority Leader Harry Reid, D-Nev., made a motion for the cloture vote before the August recess in hopes of getting a final bill through Congress quickly.

Patent Reform Clears House, But Provisions On PTO Fees, Patent Term Extension Differ From Senate

The Medicines Company and the Appropriations Committee score victories as the House clears the bill by a vote of 304 to 117.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS072626

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel